Sitagliptin: shortage, pharmacy cost, Medicare spending, recalls

Whether the FDA lists this drug as in short supply.

The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.

The national average price retail pharmacies pay to buy it (NADAC).

The lowest-cost generic on file is Sitagliptin Phosphate 25 Mg Tablet: pharmacies pay about $3.61 each, or $108.35 for 30.

This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.

Medicare Part D spending by product, from the latest annual file (2024).

In 2024, Medicare Part D plans and their members paid $3.81 billion for the 2 products below. That is down 1% from $3.87 billion in 2020.

Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Janumet, Janumet XR, Sitagliptin-Metformin, Steglujan.

Recalls reported to the FDA that name this drug.

The FDA has 2 recall records that name sitagliptin in the product description (2 Class II).

• 20131
• 20221

Most recent 2

• Class IIMERCK SHARP & DOHME CORP

  Mar 31, 2022 · Terminated · #D-0746-2022

  Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)

  Reason: Presence of foreign substance: Presence of stainless steel particulates in tablets.

• Class IIAidapak Services, LLC

  Jul 2, 2013 · Terminated · #D-774-2014

  sitaGLIPtin PHOSPHATE, Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00006011231.

  Reason: Labeling: Label Mixup: sitaGLIPtin PHOSPHATE, Tablet, 50 mg may be potentially mis-labeled as one of the following drugs: LACTOBACILLUS, Tablet, 0 mg, NDC 64980012950, Pedigree: AD62992_1, EXP: 5/23/2014; CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: W002860, EXP: 6/7/2014.

A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.